ES2151941T3 - Medrogestona. - Google Patents

Medrogestona.

Info

Publication number
ES2151941T3
ES2151941T3 ES95302934T ES95302934T ES2151941T3 ES 2151941 T3 ES2151941 T3 ES 2151941T3 ES 95302934 T ES95302934 T ES 95302934T ES 95302934 T ES95302934 T ES 95302934T ES 2151941 T3 ES2151941 T3 ES 2151941T3
Authority
ES
Spain
Prior art keywords
alpha
beta
dione
ene
dimethylpregnan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95302934T
Other languages
English (en)
Inventor
Michael William Winkley
Robert Dempster Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/239,187 external-priority patent/US5428151A/en
Application filed by American Home Products Corp filed Critical American Home Products Corp
Application granted granted Critical
Publication of ES2151941T3 publication Critical patent/ES2151941T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

UN PROCESO PARA LA PRODUCCION DE MEDROGESTRONA, EN EL QUE, EN UN PASO INTERMEDIO, SE OBTIENE EL SOLVATO 3{BE},5{AL},6{BE}TRIHIDROXI-6{AL},17{AL}-DIMETILPREGNAN20-UNO MONOMETANOLATO COMO UN COMPUESTO SOLIDO ESTABLE PARA DESPLAZAR EL DISOLVENTE ORGANICO DE UNA SOLUCION DE 3{BE},5{AL},6{BE}-TRIHIDROXI-6{AL},17{AL}DIMETILPREGNAN20-UNO CON UN ALCANOL BAJO, Y UN ADUCTOR DIELSALDER DE 6-METILENO-17{AL}-METILPREGN-4-ENE-3,20-DIONO CON ANHIDRIDO MALEICO ES USADO COMO INTERMEDIARIO PARA LA PRODUCCION DE LA CORRESPONDIENTE SAL DE ACIDO DICARBOXILICO PARA ELIMINAR LA CONTAMINACION DE 6-METILENO-17{AL}-METILPREGN-4-ENE-3,20-DIONO DEL PRODUCTO DESEADO. OTRO INTERMEDIARIO, 6{BE}-HIDROXI6{AL},17{AL}-DIMETILPREGN-4-ENE-3,20-DIONO, HA SIDO HALLADO PARA PREVENIR LA PROLIFERACION DEL MUSCULO SUAVE Y ES UTIL PARA EL TRATAMIENTO DE LA ARTEREOSCLEROSIS Y RESTINOSIS.
ES95302934T 1994-05-05 1995-04-28 Medrogestona. Expired - Lifetime ES2151941T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/239,187 US5428151A (en) 1994-05-05 1994-05-05 Medrogestrone production

Publications (1)

Publication Number Publication Date
ES2151941T3 true ES2151941T3 (es) 2001-01-16

Family

ID=22901004

Family Applications (2)

Application Number Title Priority Date Filing Date
ES95302934T Expired - Lifetime ES2151941T3 (es) 1994-05-05 1995-04-28 Medrogestona.
ES99200264T Expired - Lifetime ES2219995T3 (es) 1994-05-05 1995-04-28 6-beta-hidroxi-6 alfa, 17 alfa-dimetilpregn-4-eno-3,20-diona, como inhibidor de la proliferacion de celulas musculares lisas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99200264T Expired - Lifetime ES2219995T3 (es) 1994-05-05 1995-04-28 6-beta-hidroxi-6 alfa, 17 alfa-dimetilpregn-4-eno-3,20-diona, como inhibidor de la proliferacion de celulas musculares lisas.

Country Status (12)

Country Link
EP (1) EP0955049B1 (es)
JP (1) JP2007119500A (es)
KR (1) KR100365601B1 (es)
AT (2) ATE197798T1 (es)
DE (2) DE69533178T2 (es)
DK (2) DK0680970T3 (es)
ES (2) ES2151941T3 (es)
HK (1) HK1009970A1 (es)
HU (1) HU226298B1 (es)
PT (2) PT680970E (es)
SI (2) SI0680970T1 (es)
TW (1) TW390886B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7129392B2 (ja) * 2018-10-26 2022-09-01 キヤノン株式会社 組成物、それを有する有機発光素子、表示装置、撮像装置、電子機器及び移動体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3170936A (en) * 1963-08-07 1965-02-23 American Home Prod Process for the preparation of 6, 17alpha-dimethyl-4, 6-pregnadiene-3, 20-dione
JPS57106698A (en) * 1980-12-22 1982-07-02 Kyowa Hakko Kogyo Co Ltd Easily absorbable map composition and preparation containing the same
JPS57106697A (en) * 1980-12-22 1982-07-02 Kyowa Hakko Kogyo Co Ltd Easily absorbable map composition and preparation containing the same

Also Published As

Publication number Publication date
SI0955049T1 (en) 2004-10-31
EP0955049A2 (en) 1999-11-10
ATE197798T1 (de) 2000-12-15
DE69533178T2 (de) 2005-07-28
PT680970E (pt) 2001-04-30
KR950032266A (ko) 1995-12-20
DE69519488T2 (de) 2001-06-07
DE69533178D1 (de) 2004-07-22
SI0680970T1 (en) 2001-02-28
HK1009970A1 (en) 1999-06-11
DK0680970T3 (da) 2000-12-27
KR100365601B1 (ko) 2003-12-24
HU226298B1 (en) 2008-08-28
HU0600432D0 (en) 2006-07-28
ATE269087T1 (de) 2004-07-15
TW390886B (en) 2000-05-21
PT955049E (pt) 2004-09-30
JP2007119500A (ja) 2007-05-17
ES2219995T3 (es) 2004-12-01
EP0955049A3 (en) 2003-01-08
EP0955049B1 (en) 2004-06-16
DK0955049T3 (da) 2004-10-11
DE69519488D1 (de) 2001-01-04

Similar Documents

Publication Publication Date Title
FR2710638B1 (fr) Procédé de préparation d'isomères d'acides benzènedicarboxyliques de haute pureté.
ATE172979T1 (de) Verfahren zur herstellung von d-maltose- monoestern mit einem hohen gehalt von 6-0'-ester und ihre verwendung in kosmetika, zahnpflegemitteln, pharmazeutik und lebensmitteln
EP0444640A3 (en) Process for biological production of organic acids
YU161791A (sh) Postupak za proizvodnju anhidrida karboksilnih kiselina
DE69128123T2 (de) Verfahren zum Herstellen selbst-ausrichtender bipolarer Transistoren mit Heteroübergang
BE840078A (fr) Procede de carboxylation de substrat organiques avec de l'anhydride carbonique
ES2151941T3 (es) Medrogestona.
ATE140925T1 (de) Neues verfahren zur herstellung von 6alpha, 9alphadifluoro-sterioden und zwischenprodukte davon
HU910054D0 (en) Process for the production of beta lactames
ES2053568T3 (es) Un procedimiento para producir esteres de acidos carboxilicos.
EP0446106A3 (en) Process for producing organic carboxylic acid esters
PL295277A1 (en) Method of obtaining 7-alpha-aminoacyl cephalosporines
FI932542A0 (fi) Foerfarande foer framstaellning av estrar av 2,2-dimetyl-3-((Z)-1-propenyl)cyklopropankarboxylsyra samt mellanprodukter
DE69116879T2 (de) Verfahren und reinigung von essigsäureanhydrid und essigsäure
FR2686897B1 (fr) Procede en continu de fabrication d'acides organiques.
ATE128471T1 (de) Neues verfahren zur herstellung delta-9(11)- steroide.
DE69110374D1 (de) Verfahren zur erhöhung des alpha/beta-verhältnisses in einer aspartamkupplungsreaktion.
BR9104254A (pt) Processo para producao de anidrido de acido carboxilico
HUT55774A (en) Process for producing 13,14-dihydro-berbane derivatives and pharmaceutical compositions containing them
FR2322124A1 (fr) Procede de transformation d'un hydroperoxyde organique en acide carboxylique
GEP19970840B (en) A process for the preparation of propionic acid derivatives and stereochemical isomers thereof

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 680970

Country of ref document: ES